• 1
    Adelman DC, Saltiel E, Klinenberg JR: The neuropsychiatric manifestations of systemic lupus erythematosus: an overview. Semin Arthritis Rheum 15: 185199, 1986
  • 2
    Bluestein HG: Nervous system disease in systemic lupus erythematosus. Immunol Allergy Clin North Am 8: 315329, 1988
  • 3
    Burnstein SL, Janoff L, McCormick K: Neuropsychiatric involvement in systemic lupus erythematosus: case report and review of the literature. J Am Osteopath Assoc 87: 626631, 1987
  • 4
    McCune WJ, Golbus J: Neuropsychiatric lupus. Rheum Dis Clin North Am 14: 149167, 1988
  • 5
    Zizic TM: Systemic lupus erythematosus: corticosteroid therapy and its complications. Md Med J 33: 370381, 1984
  • 6
    Fauci AS: Corticosteroids in autoimmune disease. Hosp Pract 18: 99114, 1983
  • 7
    Lockshin MD: Systemic lupus erythematosus: problems in management. Compr Ther 8: 710, 1982
  • 8
    Kaplan D: Systemic lupus erythematosus: corticosteroids. Clin Rheum Dis 9: 601616, 1983
  • 9
    Stevens MB, Hahn BH: Management of systemic lupus erythematosus. Bull Rheum Dis 32: 3542, 1982
  • 10
    Austin HA III, Klippel JH, Balow JE, LeRiche NGH, Steinberg AD, Plotz PH, Decker JL: Therapy of lupus nephritis: controlled trial of prednisone and cytotoxic drugs. N Engl J Med 314: 614619, 1986
  • 11
    Donadio JV Jr, Holley KE, Ferguson RH, Ilstrup DM: Progressive lupus glomerulonephritis: treatment with prednisone and combined prednisone and cyclophosphamide. Mayo Clin Proc 51: 484494, 1976
  • 12
    Cade R, Spooner G, Schlein E, Pickering M, DeQuesada A, Hokomb A, Juncos L, Richard G, Shires D, Levin D, Hackett R, Free J, Hunt R, Fregly M: Comparison of azathioprine, prednisone, and heparin alone or combined in treating lupus nephritis. Nephron 10: 3756, 1973
  • 13
    Bell CL, Partington C, Robbins M, Graziano F, Turski P, Kornguth S: Magnetic resonance imaging of central nervous system lesions in patients with lupus erythematosus: correlations with clinical remission and antineurofilament and anticardiolipin antibody titers. Arthritis Rheum 34: 432441, 1991
  • 14
    Lezak MD: Neuropsychological Assessment. Second edition. New York, Oxford University Press Inc, 1983
  • 15
    Walsh KW: Neuropsychology: A clinical approach. New York, Churchill Livingstone, 1978
  • 16
    Varney NR, Alexander B, MacIndoe JH: Reversible steroid dementia in patients without steroid psychosis. Am J Psychiatry 141: 369372, 1984
  • 17
    Wolkowitz OM, Reus VI, Weingartner H, Thompson K, Breier A, Doran A, Rubinow D, Pickar D: Cognitive effects of corticosteroids. Am J Psychiatry 147: 12971303, 1990
  • 18
    Paulson GW: Steroid-sensitive dementia. Am J Psychiatry 140: 10311033, 1983
  • 19
    Chynoweth R, Foley J: Pre-senile dementia responding to steroid therapy. Br J Psychiatry 115: 703708, 1969
  • 20
    Carbotte RM, Denburg SD, Denburg JA: Prevalence of cognitive impairment in systemic lupus erythematosus. J Nerv Ment Dis 174: 357364, 1986
  • 21
    Hay EM, Black D, Huddy A, Creed F, Tomenson B, Bernstein RM, Holt PJL: Psychiatric disorder and cognitive impairment in systemic lupus erythematosus. Arthritis Rheum 35: 411416, 1992
  • 22
    Hanly JG, Fisk JD, Sherwood G, Jones E, Jones JV, Eastwood B: Cognitive impairment in patients with systemic lupus erythematosus. J Rheumatol 19: 562567, 1992
  • 23
    Ginsburg KS, Wright EA, Larson MG, Fossel AH, Albert M, Schur PH, Liang MH: A controlled study of the prevalence of cognitive dysfunction in randomly selected patients with systemic lupus erythematosus. Arthritis Rheum 35: 776782, 1992
  • 24
    Denburg SD, Carbotte RM, Denburg JA: The effects of corticosteroids on neurocognitive functioning: A trend toward improvement (abstract). Can J Psychol 28: 132, 1987
  • 25
    Joffe RT, Denicoff KD, Rubinow DR, Tsokos G, Balow JE, Pillemer SE: Mood effects of alternate-day corticosteroid therapy in patients with systemic lupus erythematosus. Gen Hosp Psychiatry 10: 5660, 1988
  • 26
    Denburg JA, Temesvari P: The pathogenesis of neuropsychiatric lupus. Can Med Assoc J 128: 257260, 1983
  • 27
    Sackett DL: Rules of evidence and clinical recommendations on the use of antithrombotic agents. Chest 89 (suppl): 2S3S, 1986
  • 28
    Sackett DL, Haynes RB, Tugwell P: Clinical Epidemiology. Boston, Little, Brown, 1985
  • 29
    Guyatt GH, Keller JL, Jaeschke R, Rosenbloom D, Adachi JD, Newhouse MT: The n-of-1 randomized control trial: clinical usefulness. Ann Intern Med 112: 293299, 1990
  • 30
    McLeod RS, Taylor DW, Cohen Z, Cullen JB: Single-patient randomised clinical trial: use in determining optimum treatment for patient with inflammation of Kock continent ileostomy reservoir. Lancet 1: 726728, 1986
  • 31
    Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ: The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25: 12711277, 1982
  • 32
    Urowitz MB, Gladman DD, Tozman ECS, Goldsmith CH: The lupus activity criteria count (LACC). J Rheumatol 11: 783787, 1984
  • 33
    Denburg SD, Carbotte RM, Denburg JA: Cognitive impairment in systemic lupus erythematosus: a neuropsychological study of individual and group deficits. J Clin Exp Neuropsychol 9: 323339, 1987
  • 34
    Cramer JA, Smith DB, Mattson RH, Delgado Escueta AV, Collins JF: A method of quantification for the evaluation of antiepileptic therapy. Neurology 33: 2637, 1983
  • 35
    Giordani B, Sackellares JC, Miller S, Berent S, Sutela T, Seidenberg M, Boll TJ, O'Leary D, Dreifuss FE: Improvement in neuropsychological performance in patients with refractory seizures after intensive diagnostic and therapeutic intervention. Neurology 33: 489493, 1983
  • 36
    McNair DM, Lorr M, Doppelman LF: EdITS manual for the profile of mood states. San Diego, Educational and Industrial Testing Service, 1971
  • 37
    Profile of Mood States, Mental Measurements Yearbook. Eighth edition. Edited by OKBuros. Highland Park, NJ, Gryphon Press, 1978
  • 38
    Denburg JA, Carbotte RM, Denburg SD: Neuronal antibodies and cognitive function in systemic lupus erythematosus. Neurology 37: 464467, 1987
  • 39
    Denburg SD, Carbotte RM, Long AA, Denburg JA: Neuropsychological correlates of serum lymphocytotoxic antibodies in systemic lupus erythematosus. Brain Behav Immun 2: 222234, 1988
  • 40
    Long AA, Ginsberg GS, Brill-Edwards P, Johnston M, Turner C, Denburg JA, Benson WG, Cividino A, Andrew M, Hirsh J: The relationship of antiphospholipid antibodies to thromboembolic disease in systemic lupus erythematosus: a cross-sectional study. Thromb Haemost 66: 520524, 1991
  • 41
    Carbotte RM, Denburg SD, Denburg JA: Memory impairment as a predictor of subsequent neuropsychiatric problems in systemic lupus (SLE) (abstract). J Clin Exp Neuropsychol 14: 107, 1992
  • 42
    Hirohata S, Iwamoto S, Miyamoto T, Sugiyama H, Nakano K, Inokuma S: A patient with systemic lupus erythematosus presenting both central nervous system lupus and steroid induced psychosis. J Rheumatol 15: 706710, 1988
  • 43
    Perry PJ, Tsuang MT, Hwang MH: Prednisolone psychosis: clinical observation. Drug Intell Clin Pharm 18: 603609, 1984
  • 44
    Ling MHM, Perry PJ, Tsuang MT: Psychiatric side effects of corticosteroid therapy. Arch Gen Psychiatry 38: 471477, 1981
  • 45
    McEwen BS: Glucocorticoids and hippocampus: Receptors in search of a function, Adrenal Actions on Brain. Edited by DGanten, DPfaff. New York, Springer-Verlag, 1982
  • 46
    Denburg SD, Denburg JA, Carbotte RM, Fisk JD, Hanly JG: Cognitive deficits in systemic lupus erythematosus. Rheum Dis Clin North Am 19: 815831, 1993
  • 47
    Robbins ML, Kornguth SE, Bell CL, Kalinke T, England D, Turski P, Graziano FM: Antineurofilament antibody evaluation in neuropsychiatric systemic lupus erythematosus: combination with anticardiolipin antibody assay and magnetic resonance imaging. Arthritis Rheum 31: 623631, 1988
  • 48
    Chung IY, Benveniste EN: Tumor necrosis factor-α production by astrocytes: induction by lipopolysaccharide, IFN-τ and IL-1β. J Immunol 144: 29993007, 1990
  • 49
    Houssiau FA, Devogelaer JP, van Damme J, Nagant de Deuxchaisnes C, van Snick J: Interleukin-6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritides. Arthritis Rheum 31: 784788, 1988
  • 50
    Houssiau FA, Bukasa K, Sindic CJM, Van Damme J, Van Snick J: Elevated levels of the 26 K human hybridoma growth factor (interleukin 6) in cerebrospinal fluid of patients with acute infection of the central nervous system. Clin Exp Immunol 71: 320323, 1988
  • 51
    Hirohata S, Miyamoto T: Elevated levels of interleukin-6 in cerebrospinal fluid from patients with systemic lupus erythematosus and central nervous system involvement. Arthritis Rheum 33: 644649, 1990
  • 52
    How A, Dent PB, Liao S-K, Denburg JA: Antineuronal antibodies in neuropsychiatric systemic lupus erythematosus. Arthritis Rheum 28: 789795, 1985
  • 53
    Hanly JG, Behmann S, Denburg SD, Carbotte RM, Denburg JA: The association between sequential changes in serum antineuronal antibodies and neuropsychiatric systemic lupus erythematosus. Postgrad Med J 65: 622627, 1989
  • 54
    Ter Borg EJ, Horst G, Hummel EJ, Limburg PC, Kallenberg, CGCM: Measurement of increase in anti-double-stranded DNA antibody levels as a predictor of disease exacerbation in systemic lupus erythematosus: a long-term prospective study. Arthritis Rheum 33: 634643, 1990
  • 55
    Lockshin MD: Therapy for systemic lupus erythematosus. N Engl J Med 324: 189191, 1991